PharmaShots Weekly Snapshot (March 11-15, 2019)
Published: March 15, 2019 |Tags: Gates Foundation, Signs, Research, Agreement, AbCellera, Accelerate, Global Health Research
Published: March 15, 2019 |Tags: Abbott, MitraClip, Device, Receives, FDA, Expanded, Indication, Approval, Secondary Mitral Regurgitation, MR
Published: March 15, 2019 |Tags: Roche, MabThera, rituximab, Receives, EU, Approval, Rare, Autoimmune Disease, Pemphigus Vulgaris, PV
?Bayer Reports Results of Nifurtimox in P-III CHICO Study for Chagas Disease in Pediatric Patients
Published: March 15, 2019 |Tags: Bayer, Reports, Results, Nifurtimox, P-III, CHICO, Study, Chagas Disease, Pediatric, Patients
?Merck KGaA Collaborates with Iktos for its Artificial Intelligence (AI) Technology
Published: March 15, 2019 |Tags: Merck KGaA, Collaborates, Iktos, Artificial Intelligence, AI, Technology
Published: March 14, 2019 |Tags: Merck, Keytruda, Chemotherapy, Receive, EU, Approval, NSCLC
Hoth Therapeutics Signs a License Agreement with UMB and Isoprene Pharmaceuticals
Published:March 14, 2019 |Tags: Hoth Therapeutics, Signs, License Agreement, UMB, Isoprene Pharmaceuticals
Roches Hemlibra Receives EUs Approval for Severe Haemophilia A without Factor VIII Inhibitors
Published: March 14, 2019 |Tags: Roche, Hemlibra, Receives, EU, Approval, Severe, Haemophilia A, Factor VIII Inhibitors
Smith & Nephew to Acquire Osiris Therapeutics for $660M
Published: March 14, 2019 |Tags: Smith & Nephew, Acquire, Osiris Therapeutics, $660M
Retrotopes RT001 Receives EMAs Orphan Drug Designation for Infantile Neuroaxonal Dystrophy (INAD)
Published:March 14, 2019 |Tags: Retrotope, RT001, Receives, EMA, Orphan Drug Designation, Infantile Neuroaxonal Dystrophy, INAD
Sun Pharmas SPARC Signs a Research Collaboration with HitGen to Develop Therapies
Published: March 13, 2019 |Tags:Sun Pharma, SPARC, Announces, Research, Collaboration, HitGen, Develop, Novel, Small Molecules
Exactech to Acquire XpandOrtho for its Ligament-Balancing Technology
Published: March 13, 2019 |Tags: Exactech, Acquire, XpandOrtho, Ligament-Balancinag Technology
Published: March 13, 2019 |Tags: Akebia Therapeutics, Reports, Positive, Results, Vadadustat, P-III, J01, J03, Studies, Anemia, Chronic Kidney Disease, CKD, Japan
?Secura Bio Acquires WW Commercialization Rights to Novartis Farydak for R/R Multiple Myeloma
Published: March 13, 2019 |Tags: Secura Bio, Acquired, WW, Commercialization, Rights, Novartis, Farydak, R/R, Multiple Myeloma
Published: March 13, 2019 |Tags: ? Vertex, Symdeko, tezacaftor, ivacaftor, Receives, TGA, Approval, Cystic Fibrosis, CFTR Gene, Mutation, Australia
Eli Lilly Reports Positive Results of Cyramza (ramucirumab) in P-III RELAY Study for mNSCLC?
Published:March 12, 2019 |Tags: Eli Lilly, Reports, Positive, Results, Cyramza, ramucirumab, P-III, RELAY, Study, mNSCLC
? Paige.AI Receives FDAs Breakthrough Designation for its Artificial Intelligence in Pathology
Published: March 12, 2019 |Tags: Paige.AI, Receives, FDA, Breakthrough Designation, Artificial Intelligence, Pathology
Allergan Reports Acceptance of NDA from FDA for its Ubrogepant for Migraine
Published:March 12, 2019 |Tags: Allergen, Reports, Acceptance, NDA, FDA, Ubrogepant, Migraine
Published:March 12, 2019 |Tags: Pfizer, Trazimera, trastuzumab-qyyp, Receives, FDA, Approval, HER-2, Overexpressing, Breast Cancer, m-Gastric Cancer
?AstraZeneca and Seres Therapeutics Enters into Research Collaboration for 3yrs.
Published: March 12, 2019 | Tags: AstraZeneca, Seres Therapeutics, Enters, Research, Collaboration, 3yrs.
?Roches Tecentriq + Abraxane Receive FDAs Accelerated Approval for mTNBCa
Published: March 11, 2019 | Tags: Roche, Tecentriq, Abraxane, Receives, FDA, Accelerated, Approval, mTNBC
Almirall's Ilumetri (tildrakizumab) Receives NICEs Provisional Approval for Moderate-To-Severe Plaque Psoriasis
Published: March 11, 2019 |Tags: Almirall, Ilumetri, tildrakizumab, Receives, NICE, Provisional, Approval, Moderate, Severe, Plaque Psoriasis
Published: March 11, 2019 |Tags: MSD, Signs, License, Agreement, Kings College London, Wellcomes Innovations, Develop, Chronic, Neuropathic, Pain, Therapies
Published: March 11, 2019 |Tags: Roche, Ventana PD-L1 SP142, Receives, FDA, Approval, Identifying, Triple-Negative Breast Cancer, TNBC
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com